FDA Inspection 1013147 — Haematologic Technologies, LLC

Haematologic Technologies, LLC — FEI 3010163994

The FDA completed an inspection of Haematologic Technologies, LLC on May 11, 2017 in Essex Junction, VT. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 11, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Essex Junction, VT (United States)

Citations

IDCFRDescription
240621 CFR 211.194(a)(8)Identification of Person Performing Review of Lab Records